Seoul National University Hospital

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 2003-01-01

Employees: 501

Market Cap: -

Website: https://www.snubh.org

Clinical Trials

MIrabegron With oveRACtive bLadder Symptoms in mEn

Phase 4

Conditions: Overactive Bladder

Interventions: Drug: placebo
Drug: mirabegron

First Posted Date: 2015-02-11

Last Posted Date: 2015-02-11

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 462

Registration Number: NCT02361502

Locations: 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of
🇰🇷
Korea University Ansan Hospital, Ansan, Korea, Republic of
🇰🇷
Pusan National University Hospital, Busan, Korea, Republic of

and more 11 locations

The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection

Not Applicable

Terminated

Conditions: Helicobacter Infection

Interventions: Drug: 14 days empirical bismuth quadruple therapy (Proton pump inhibitor)
Procedure: H. pylori culture and antimicrobial susceptibility testing
Drug: 7 days tailored therapy Proton Pump Inhibitor
Drug: Metronidazole
Drug: Tetracycline
Drug: Moxifloxacin
Drug: tripotassium dicitrate bismuthate
Drug: Amoxicillin

First Posted Date: 2015-02-10

Last Posted Date: 2023-04-13

Lead Sponsor: Seoul National University Bundang Hospital

Target Recruit Count: 370

Registration Number: NCT02359331

Locations: 🇰🇷
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of

The Diagnostic Validity of the Urea Breath Test

Not Applicable

Completed

Conditions: Helicobacter Pylori Infection

Interventions: Drug: Citric acid

First Posted Date: 2015-02-10

Last Posted Date: 2019-04-18

Lead Sponsor: Seoul National University Bundang Hospital

Target Recruit Count: 1200

Registration Number: NCT02359942

Locations: 🇰🇷
Seoul National University Hospital, Seongnam, Korea, Republic of

Posthemorrhoidectomy Pain Management With Electronic Bidet or Sitz Bath

Phase 2

Conditions: Hemorrhoid

Interventions: Other: Electronic bidet
Other: Sitz bath

First Posted Date: 2015-02-02

Last Posted Date: 2020-11-12

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 76

Registration Number: NCT02353156

The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori

Not Applicable

Completed

Conditions: Helicobacter Infection

Interventions: Drug: 14 day PBMT group
Drug: 14 day MEA group
Procedure: H. pylori culture and antimicrobial susceptibility test

First Posted Date: 2015-01-29

Last Posted Date: 2016-10-04

Lead Sponsor: Seoul National University Bundang Hospital

Target Recruit Count: 219

Registration Number: NCT02349685

The Effectiveness of Tailored Messages on the Usage of Emollient in Patients With Atopic Dermatitis

Not Applicable

Completed

Conditions: Dermatitis, Atopic

Interventions: Behavioral: Tailored leaflet group
Behavioral: Control group

First Posted Date: 2015-01-22

Last Posted Date: 2018-03-15

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 24

Registration Number: NCT02343861

Locations: 🇰🇷
Department of Dermatology, Seoul National University Boramae Hospital, Seoul, Korea, Republic of

A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer

Phase 1

Completed

Conditions: Fallopian Tube Carcinoma
Primary Peritoneal Carcinoma
Epithelial Ovarian Carcinoma

Interventions: Drug: weekly cisplatin
Drug: weekly paclitaxel
Device: oncothermia

First Posted Date: 2015-01-22

Last Posted Date: 2024-07-12

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 12

Registration Number: NCT02344095

Locations: 🇰🇷
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of

Diagnostic Accuracy of Nontuberculous Mycobacterial Lung Disease Based on Chest CT

Completed

Conditions: Mycobacterium Infections, Nontuberculous

First Posted Date: 2015-01-19

Last Posted Date: 2016-04-20

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 132

Registration Number: NCT02340897

Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy

Phase 4

Completed

Conditions: Type 2 Diabetes

Interventions: Drug: Sitagliptin
Drug: Dapagliflozin
Drug: Lobeglitazone
Drug: Glimepirde
Drug: Metformin

First Posted Date: 2015-01-14

Last Posted Date: 2022-01-04

Lead Sponsor: Seoul National University Bundang Hospital

Target Recruit Count: 78

Registration Number: NCT02338921

Locations: 🇰🇷
Soo Lim, Seongnam, Gyeonggi, Korea, Republic of

Pharmacokinetic Study of Lipo-PGE1 for Prevention of VOD After HSCT

Phase 2

Conditions: Veno-occlusive Disease
Child

Interventions: Drug: lipoprostaglandin E1

First Posted Date: 2015-01-14

Last Posted Date: 2021-03-30

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 30

Registration Number: NCT02338440

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Chongno-gu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy